Table 1.
Characteristics of study participants
| Men (n = 41) | Women (n = 20) | |
|---|---|---|
| Age (years) | 63.7 ± 8.1 | 63.3 ± 9.6 |
| BMI (kg/m2) | 27.2 ± 2.7 | 29.0 ± 4.4 |
| Waist circumference (cm) | 95.0 ± 6.4 | 101.6 ± 10.5 |
| Systolic blood pressure (mmHg) | 138.1 ± 12.9 | 133.3 ± 14.9 |
| Diastolic blood pressure (mmHg) | 87.3 ± 10.4 | 80.9 ± 8.6 |
| Triglycerides (mg/dL) | 191.4 ± 96.1 | 169.4 ± 87.3 |
| HDL-cholesterol (mg/dL) | 46.5 ± 10.5 | 57.4 ± 18.6 |
| Non-HDL-cholesterol (mg/dL) | 185.5 ± 95.6 | 208.8 ± 153.7 |
| LDL-cholesterol (mg/dL) | 128.1 ± 36.2 | 136.8 ± 35.1 |
| Fasting plasma glucose (mg/dL) | 108.5 ± 28.5 | 100.4 ± 14.7 |
| Hemoglobin Alc (%) | 5.7 ± 1.1 | 5.7 ± 0.4 |
| Insulin (uU/mL)* | 15.6 (2.7-119.2) | 11.8 (2.6–49.9) |
| HOMA-IR* | 6.0 (0.68–40.2) | 3.0 (0.7–10.2) |
| Medication for hypertension | 20 (48.8%) | 2 (4.9%) |
| Medication for diabetes mellitus | 13 (65.0%) | 2 (10.0%) |
*
Data are means ± standard deviation, geometric mean and range. These variables are shown in the original scale after analysis using log (natural)-transformed values.
BMI, body mass index; HDL, high-density lipoprotein; HOMA-IR, homeostasis model assessment insulin resistance; LDL, low-density lipoprotein.